← The SEC Ephemeris: the whole map
EMD Serono, Inc. cladribine
In the graph: all 1 documents (12 pages).
- Application
- NDA 022561
- Ticker
- EMD Serono, Inc.
- Product
- cladribine
- Disease area
- Not yet classified
- Response path
- Not yet classified
- Complete Response Letters
- February 28, 2011
From FDA letters and SEC filings. Not investment or medical advice.